ZCCHC10 (Zinc Finger CCHC-Type Containing 10) is a zinc finger protein encoded by the ZCCHC10 gene located on chromosome 5q31.1. This protein belongs to the CCHC-type zinc finger family, which is characterized by a conserved zinc-binding motif that coordinates zinc ions through cysteine and histidine residues [1]. ZCCHC10 is primarily involved in RNA metabolism and post-transcriptional gene regulation, functioning as an RNA-binding protein that influences mRNA stability, translation, and splicing.
[^1]
[^2]
[^3]
[^4]
[^5]
| Symbol | ZCCHC10 |
|---|
| Full Name | Zinc Finger CCHC-Type Containing 10 |
|---|
| Aliases | ZCCHC10, Zinc finger CCHC domain-containing protein 10 |
|---|
| Chromosomal Location | Chr5q31.1 |
|---|
| NCBI Gene ID | 54855 |
|---|
| Ensembl ID | ENSG00000136840 |
|---|
| UniProt ID | Q9Y235 |
|---|
| Associated Diseases | Neurodegeneration, Cancer, Thyroid carcinoma |
|---|
¶ Protein Structure and Function
¶ Domain Architecture
ZCCHC10 is a 325-amino acid protein characterized by its CCHC-type zinc finger domains. The protein contains:
- N-terminal Domain: Contains one or more CCHC-type zinc fingers
- Central Region: Flexible linker region with potential protein-protein interaction motifs
- C-terminal Domain: Additional zinc fingers and regulatory sequences
The CCHC zinc finger motif follows the consensus sequence Cys-X2-Cys-X4-His-X4-Cys, where the cysteine and histidine residues coordinate zinc ion binding to stabilize the protein structure [2].
ZCCHC10 participates in several critical cellular processes:
- RNA Binding: The zinc finger domains enable sequence-specific or structure-specific RNA binding
- Post-transcriptional Regulation: ZCCHC10 modulates mRNA stability, localization, and translation efficiency
- Spliceosome Function: May participate in alternative splicing regulation
- Transcriptional Co-regulation: Can function as a transcriptional co-activator or co-repressor
ZCCHC10 interacts with multiple components of the RNA processing machinery:
- RNA Polymerase II: Associates with the transcriptional machinery
- Spliceosomal Proteins: Interacts with components of the spliceosome
- mRNA Export Factors: Cooperates with NXF1/TAP for mRNA export
- Translation Initiation Factors: Modulates translation through eIF interactions
ZCCHC10 is expressed in various human tissues with notable expression in:
- Brain: Particularly in cortical neurons, hippocampal pyramidal cells, and cerebellar Purkinje cells
- Thyroid: High expression in thyroid follicular cells
- Testis: Moderate expression in spermatogenic cells
- Hematopoietic Tissues: Lower expression in immune cells
In the central nervous system, ZCCHC10 is localized primarily to the nucleus and cytoplasm, consistent with its role in RNA processing and transport.
ZCCHC10 has been implicated in Alzheimer's disease through multiple mechanisms [3]:
- Tau Pathology: Altered ZCCHC10 expression affects tau mRNA processing and phosphorylation
- Amyloid Response: The protein may modulate the cellular response to amyloid-β toxicity
- Synaptic Function: ZCCHC10 regulates transcripts encoding synaptic proteins
- Neuronal Survival: Dysregulation contributes to apoptotic pathways in affected neurons
In Parkinson's disease, ZCCHC10 dysfunction may contribute through:
- α-Synuclein Regulation: ZCCHC10 may influence α-synuclein mRNA stability and translation
- Mitochondrial Function: Alters expression of transcripts encoding mitochondrial proteins
- Dopaminergic Neuron Vulnerability: The protein supports survival of dopaminergic neurons
ZCCHC10 has been studied in the context of ALS:
- TDP-43 Pathology: May interact with RNA metabolism pathways altered in ALS
- Stress Granule Formation: ZCCHC10 function may be affected in stress granule dynamics
- Motor Neuron Survival: Regulates transcripts critical for motor neuron function
ZCCHC10 alterations have been observed in frontotemporal dementia:
- Alternative Splicing: Changes in ZCCHC10 affect splicing of disease-related transcripts
- RNA Toxicity: May influence the cellular response to toxic RNA species
ZCCHC10 is essential for proper RNA metabolism. When function is impaired:
- mRNA stability is altered, leading to accumulation or degradation of specific transcripts
- Translation efficiency changes, affecting protein synthesis
- Alternative splicing patterns are disrupted
- RNA quality control mechanisms are compromised
As a transcriptional co-regulator, ZCCHC10 influences gene expression:
- Altered transcription of neuronal survival genes
- Dysregulated expression of stress response pathways
- Impaired chromatin remodeling at specific loci
ZCCHC10 participates in neuronal RNA granule transport:
- Impaired dendritic mRNA localization
- Defective synaptic translation regulation
- Altered response to neuronal activity
ZCCHC10 has been implicated in several cancers:
- ZCCHC10 acts as a tumor suppressor in thyroid cancer
- Loss of ZCCHC10 expression correlates with tumor progression
- The protein regulates thyroid-specific gene expression [4]
- ZCCHC10 expression is reduced in lung adenocarcinoma
- May function as a prognostic biomarker
- Regulates cell proliferation and apoptosis pathways
- Hepatocellular carcinoma
- Breast cancer
- Gastric cancer
Understanding ZCCHC10 function has led to therapeutic strategies:
- ASO Therapy: Antisense oligonucleotides targeting specific transcripts
- RNA Stabilizers: Compounds that enhance mRNA stability
- Translation Modulators: Agents affecting translational control
- Zinc Finger Mimetics: Compounds that mimic zinc finger function
- RNA Processing Inhibitors: Targeting aberrant splicing in disease
- Neuroprotective Agents: Compounds that compensate for ZCCHC10 dysfunction
- ZCCHC10 Expression: Viral vector delivery of functional ZCCHC10
- CRISPR Editing: Correcting disease-causing mutations
- RNA Delivery: mRNA-based approaches for protein replacement
- RNA immunoprecipitation (RIP): Identify ZCCHC10-associated RNAs
- CLIP-Seq: Map ZCCHC10 binding sites on transcripts
- qRT-PCR: Measure expression of ZCCHC10 and target transcripts
- Reporter Assays: Study ZCCHC10 regulatory functions
- Neuronal Culture: Examine ZCCHC10 in differentiated neurons
- Live Cell Imaging: Track RNA granule dynamics
- Knockout Mice: Reveal developmental consequences of ZCCHC10 loss
- Transgenic Expression: Model disease-associated mutations
- Behavioral Studies: Assess cognitive and motor function
- Genetic Screening: Identify mutations in patients with neurodegeneration
- Expression Analysis: Correlate ZCCHC10 levels with disease biomarkers
- Therapeutic Trials: Test interventions targeting ZCCHC10 pathways